Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Human Molecular Genetics, 18, 22, S. 4442-456
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2009
- Ereignis
-
Veröffentlichung
- (wo)
-
Oxford
- (wer)
-
Oxford University Press
- (wann)
-
2009
- Urheber
- DOI
-
10.1093/hmg/ddp372
- URN
-
urn:nbn:de:bvb:384-opus4-845083
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Antoniou, A. C.
- Sinilnikova, O. M.
- Ditsch, Nina
- Universität Augsburg
- Oxford University Press
Entstanden
- 2009
Ähnliche Objekte (12)
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers